Cargando…

Gender-related challenges facing oncologists: the results of the ESMO Women for Oncology Committee survey

BACKGROUND: Although women account for a growing proportion of the oncology workforce, there is evidence they are under-represented in leadership roles. To gain further insights into this issue and extend understanding of gender challenges, the European Society for Medical Oncology Women for Oncolog...

Descripción completa

Detalles Bibliográficos
Autores principales: Banerjee, Susana, Dafni, Urania, Allen, Tamara, Arnold, Dirk, Curigliano, Giuseppe, Garralda, Elena, Garassino, Marina Chiara, Haanen, John, Hofstädter-Thalmann, Eva, Robert, Caroline, Sessa, Cristiana, Tsourti, Zoi, Zygoura, Panagiota, Peters, Solange
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6157518/
https://www.ncbi.nlm.nih.gov/pubmed/30273420
http://dx.doi.org/10.1136/esmoopen-2018-000422
_version_ 1783358281173958656
author Banerjee, Susana
Dafni, Urania
Allen, Tamara
Arnold, Dirk
Curigliano, Giuseppe
Garralda, Elena
Garassino, Marina Chiara
Haanen, John
Hofstädter-Thalmann, Eva
Robert, Caroline
Sessa, Cristiana
Tsourti, Zoi
Zygoura, Panagiota
Peters, Solange
author_facet Banerjee, Susana
Dafni, Urania
Allen, Tamara
Arnold, Dirk
Curigliano, Giuseppe
Garralda, Elena
Garassino, Marina Chiara
Haanen, John
Hofstädter-Thalmann, Eva
Robert, Caroline
Sessa, Cristiana
Tsourti, Zoi
Zygoura, Panagiota
Peters, Solange
author_sort Banerjee, Susana
collection PubMed
description BACKGROUND: Although women account for a growing proportion of the oncology workforce, there is evidence they are under-represented in leadership roles. To gain further insights into this issue and extend understanding of gender challenges, the European Society for Medical Oncology Women for Oncology (W4O) Committee undertook a survey of female and male oncologists in 2016. DESIGN: The 2016 W4O questionnaire included questions on (1) Demographics and professional environment, (2) Gender impact on career development, (3) Challenges for career progression and inappropriate behaviour experienced in the workplace, (4) Barriers for gender parity and (5) The gender gap. Between July and September 2016, the online survey was available to male and female clinical and academic oncology healthcare professionals in the EU and internationally. RESULTS: Responses were analysed from 462 oncologists, of whom 76.7 % were women. Of female respondents, 45.5 % had a managerial or leadership role, compared with 65 % of male respondents (p<0.001). Men were more likely to have leadership roles, even in clinical teams with more women than men. Women respondents were more likely to consider their gender had a major impact on their career than men: 35.9 % vs 20.9 % (p<0.001). The biggest challenge to career progression for women was work and family balance (64.2%). Of female respondents, 14.4 % believed there had been significant or major progress in closing the gender pay gap compared with 39.3 % of men (p<0.001). Of female participants, 37.7 % reported they had encountered unwanted sexual comments by a superior or colleague. CONCLUSIONS: New initiatives are needed to address under-representation of women oncologists in leadership roles, including greater and concrete promotion of work–life balance, development and leadership training for women, and more support for flexible working. The fact that over a third of women in the survey had encountered unwanted sexual comments at work is of great concern and must be urgently addressed.
format Online
Article
Text
id pubmed-6157518
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-61575182018-09-28 Gender-related challenges facing oncologists: the results of the ESMO Women for Oncology Committee survey Banerjee, Susana Dafni, Urania Allen, Tamara Arnold, Dirk Curigliano, Giuseppe Garralda, Elena Garassino, Marina Chiara Haanen, John Hofstädter-Thalmann, Eva Robert, Caroline Sessa, Cristiana Tsourti, Zoi Zygoura, Panagiota Peters, Solange ESMO Open Original Research BACKGROUND: Although women account for a growing proportion of the oncology workforce, there is evidence they are under-represented in leadership roles. To gain further insights into this issue and extend understanding of gender challenges, the European Society for Medical Oncology Women for Oncology (W4O) Committee undertook a survey of female and male oncologists in 2016. DESIGN: The 2016 W4O questionnaire included questions on (1) Demographics and professional environment, (2) Gender impact on career development, (3) Challenges for career progression and inappropriate behaviour experienced in the workplace, (4) Barriers for gender parity and (5) The gender gap. Between July and September 2016, the online survey was available to male and female clinical and academic oncology healthcare professionals in the EU and internationally. RESULTS: Responses were analysed from 462 oncologists, of whom 76.7 % were women. Of female respondents, 45.5 % had a managerial or leadership role, compared with 65 % of male respondents (p<0.001). Men were more likely to have leadership roles, even in clinical teams with more women than men. Women respondents were more likely to consider their gender had a major impact on their career than men: 35.9 % vs 20.9 % (p<0.001). The biggest challenge to career progression for women was work and family balance (64.2%). Of female respondents, 14.4 % believed there had been significant or major progress in closing the gender pay gap compared with 39.3 % of men (p<0.001). Of female participants, 37.7 % reported they had encountered unwanted sexual comments by a superior or colleague. CONCLUSIONS: New initiatives are needed to address under-representation of women oncologists in leadership roles, including greater and concrete promotion of work–life balance, development and leadership training for women, and more support for flexible working. The fact that over a third of women in the survey had encountered unwanted sexual comments at work is of great concern and must be urgently addressed. BMJ Publishing Group 2018-09-21 /pmc/articles/PMC6157518/ /pubmed/30273420 http://dx.doi.org/10.1136/esmoopen-2018-000422 Text en © Author (s) (or their employer(s)) 2018. Re-use permitted under CC BY-NC. No commercial re-use. Published by BMJ on behalf of the European Society for Medical Oncology. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, any changes made are indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0
spellingShingle Original Research
Banerjee, Susana
Dafni, Urania
Allen, Tamara
Arnold, Dirk
Curigliano, Giuseppe
Garralda, Elena
Garassino, Marina Chiara
Haanen, John
Hofstädter-Thalmann, Eva
Robert, Caroline
Sessa, Cristiana
Tsourti, Zoi
Zygoura, Panagiota
Peters, Solange
Gender-related challenges facing oncologists: the results of the ESMO Women for Oncology Committee survey
title Gender-related challenges facing oncologists: the results of the ESMO Women for Oncology Committee survey
title_full Gender-related challenges facing oncologists: the results of the ESMO Women for Oncology Committee survey
title_fullStr Gender-related challenges facing oncologists: the results of the ESMO Women for Oncology Committee survey
title_full_unstemmed Gender-related challenges facing oncologists: the results of the ESMO Women for Oncology Committee survey
title_short Gender-related challenges facing oncologists: the results of the ESMO Women for Oncology Committee survey
title_sort gender-related challenges facing oncologists: the results of the esmo women for oncology committee survey
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6157518/
https://www.ncbi.nlm.nih.gov/pubmed/30273420
http://dx.doi.org/10.1136/esmoopen-2018-000422
work_keys_str_mv AT banerjeesusana genderrelatedchallengesfacingoncologiststheresultsoftheesmowomenforoncologycommitteesurvey
AT dafniurania genderrelatedchallengesfacingoncologiststheresultsoftheesmowomenforoncologycommitteesurvey
AT allentamara genderrelatedchallengesfacingoncologiststheresultsoftheesmowomenforoncologycommitteesurvey
AT arnolddirk genderrelatedchallengesfacingoncologiststheresultsoftheesmowomenforoncologycommitteesurvey
AT curiglianogiuseppe genderrelatedchallengesfacingoncologiststheresultsoftheesmowomenforoncologycommitteesurvey
AT garraldaelena genderrelatedchallengesfacingoncologiststheresultsoftheesmowomenforoncologycommitteesurvey
AT garassinomarinachiara genderrelatedchallengesfacingoncologiststheresultsoftheesmowomenforoncologycommitteesurvey
AT haanenjohn genderrelatedchallengesfacingoncologiststheresultsoftheesmowomenforoncologycommitteesurvey
AT hofstadterthalmanneva genderrelatedchallengesfacingoncologiststheresultsoftheesmowomenforoncologycommitteesurvey
AT robertcaroline genderrelatedchallengesfacingoncologiststheresultsoftheesmowomenforoncologycommitteesurvey
AT sessacristiana genderrelatedchallengesfacingoncologiststheresultsoftheesmowomenforoncologycommitteesurvey
AT tsourtizoi genderrelatedchallengesfacingoncologiststheresultsoftheesmowomenforoncologycommitteesurvey
AT zygourapanagiota genderrelatedchallengesfacingoncologiststheresultsoftheesmowomenforoncologycommitteesurvey
AT peterssolange genderrelatedchallengesfacingoncologiststheresultsoftheesmowomenforoncologycommitteesurvey